Robust generation of neutralising antibodies against Omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 years (2024)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2023.08.014
Publication URI: http://dx.doi.org/10.1016/j.jinf.2023.08.014
Type: Journal Article/Review
Parent Publication: Journal of Infection
Issue: 1